4//SEC Filing
Rombotis Spiro George 4
Accession 0001104659-23-077661
CIK 0001130166other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:58 PM ET
Size
5.8 KB
Accession
0001104659-23-077661
Insider Transaction Report
Form 4
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
- Award
Stock Option (right to buy)
2023-06-30+110,000→ 110,000 totalExercise: $0.59From: 2024-06-30Exp: 2033-06-30→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The reporting person received an award of 110,000 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001357396
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:58 PM ET
- Size
- 5.8 KB